TY - JOUR
T1 - Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus
T2 - A Randomized Cross-Over Trial
AU - Kristensen, Peter Lommer
AU - Pedersen-Bjergaard, Ulrik
AU - Kjær, Troels Wesenberg
AU - Olsen, Niels Vidiendal
AU - Dela, Flemming
AU - Holst, Jens Juul
AU - Faber, Jens
AU - Tarnow, Lise
AU - Thorsteinsson, Birger
PY - 2013/4/5
Y1 - 2013/4/5
N2 - The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia.
AB - The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia.
U2 - 10.1371/journal.pone.0059672
DO - 10.1371/journal.pone.0059672
M3 - Journal article
C2 - 23577069
VL - 8
SP - 1
EP - 8
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 4
M1 - e59672
ER -